Abstract-S-nitrosoalbumin (SNO-Alb) is a major reservoir of releasable nitric oxide (NO) in plasma. In preeclampsia, a pregnancy-specific disorder associated with endothelial dysfunction, we previously found significant elevations in plasma SNO-Alb concentrations and decreased plasma ascorbate (Asc) levels. This increased SNO-Alb may result from low-plasma Asc if Asc, along with transition metals (eg, copper [Cu]) are necessary for release of NO from S-nitrosothiols. We propose that vasodilator effects of SNO-Alb, mediated by release of NO, are fully realized only when Asc/Cu availability is sufficient. Relaxation responses to SNO-Alb or the control reduced human serum albumin (SH-Alb), and responses to pooled plasma from normal or preeclamptic pregnancies were examined in isolated mouse arteries. Arteries preconstricted with phenylephrine were exposed to SNO-Alb or SH-Alb at physiologically relevant concentrations. When free Cu was added in excess (10 mol/L), NO release was not dependent on Asc. However, when Cu was added at lower (physiological) levels, NO release was dependent on Asc. The addition of Asc and Cu to SNO-Alb stimulated vasodilatory responses in isolated arteries Ͼ90%, whereas no change in the SH-Alb (5%) response was observed. Preeclampsia plasma with higher levels of SNO-Alb caused arteries to relax 44.1Ϯ4.7%, whereas normal pregnancy plasma caused 11.9Ϯ4.2% relaxation (Pϭ0.007). These data indicate that SNO-Alb alone or in plasma can act as a potent vasodilator, and that sufficient Asc/Cu promotes this action. We suggest that the higher circulating levels of SNO-Alb, in women with preeclampsia, reflect a deficiency in Asc/Cu-mediated release of NO from SNO-Alb. Key Words: preeclampsia Ⅲ pregnancy Ⅲ nitric oxide Ⅲ oxidative stress Ⅲ antioxidants P reeclampsia is a major cause of maternal and neonatal morbidity and mortality. The clinical manifestations of this pregnancy-specific disorder include hypertension and proteinuria developing after 20 weeks of gestation. Placental abnormalities and maternal endothelial dysfunction/activation are thought to contribute to vasospasm and the onset of the maternal syndrome. It has been hypothesized that oxidative stress plays a role in the pathophysiology of preeclampsia. Evidence of oxidative stress in combination with profound depletion of plasma ascorbate (Asc) has been reported in women with preeclampsia. [1][2][3][4] Asc concentrations in women with preeclampsia are nearly half those of matched normal pregnant controls (Ϸ40 versus 25 mol/L). 5 The implications of this reduction in plasma Asc are currently not clear. Plasma Asc levels are inversely related to blood pressures in men without a history of hypertension. 6,7 Asc and vitamin E supplementation in women at high risk for preeclampsia was associated with a reduction in markers of endothelial dysfunction and in the incidence of preeclampsia. 5,8 Although the decreased incidence of preeclampsia was associated with decreased biochemical indices of oxidative stress and poor placental function, the me...